North America Hematological Disorders Market Outlook to 2033: Hematology Tests and Hemostasis Tests

All the vital news, analysis, and commentary curated by our industry experts.

$5995

Buy Report

Published: September 04, 2025 Report Code: GDME20410CRDB-ST

Report Overview
Key Players
Table of Contents
Table
Figures

GlobalData’s “North America Hematological Disorders Market Outlook to 2033” is a comprehensive databook report, covering key market data on the North America Hematological Disorders market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Hematology Tests and Hemostasis Tests

The North America Hematological Disorders Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2023 company share data for Hematological Disorders Market.
• Global corporate-level profiles of key companies operating within the North America Hematological Disorders Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

North America Hematological Disorders is segmented as follows – _x000D_

• Hematology Tests_x000D_

• Hemostasis Tests

Reasons to Buy

The North America Hematological Disorders Market report helps you to develop –

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Abbott Laboratories_x000D_
F. Hoffmann-La Roche Ltd_x000D_
Sysmex Corp_x000D_
Siemens AG_x000D_
WerfenLife SA_x000D_
Danaher Corp_x000D_
Diagnostica Stago SAS_x000D_
Quidel Corp_x000D_
Thermo Fisher Scientific Inc_x000D_
Siemens Healthineers AG

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 5

2 Introduction 7

2.1 What Is This Report About? 7

2.2 Hematological Disorders Market Segmentation 7

2.3 Definitions of Markets Covered in the Report 8

3 Hematological Disorders Market, North America 11

3.1 Hematological Disorders Market, North America, Revenue ($m), 2018-2033 11

3.2 Hematological Disorders Market, North America, Revenue ($m), 2018-2033 13

3.3 Hematological Disorders Market, North America, Volume (Units), 2018-2033 16

3.4 Hematological Disorders Market, North America, Volume (Units), 2018-2033 18

3.5 Hematological Disorders Market, North America, Company Share by Revenue ($m), 2024 20

4 Hematological Disorders Market, Canada 22

4.1 Hematological Disorders Market, Canada, Revenue ($m), 2018-2033 22

4.1.1 Hematology Tests Market, Canada, Revenue ($m), by Segment, 2018-2033 24

4.1.2 Hemostasis Tests Market, Canada, Revenue ($m), by Segment, 2018-2033 26

4.2 Hematological Disorders Market, Canada, Volume (Units), 2018-2033 28

4.2.1 Hematology Tests Market, Canada, Volume (Units), by Segment, 2018-2033 30

4.2.2 Hemostasis Tests Market, Canada, Volume (Units), by Segment, 2018-2033 34

4.3 Hematological Disorders Market, Canada, Average Price ($) , 2018-2033 37

4.4 Hematological Disorders Market, Canada, Company Share by Revenue ($m), 2024 39

5 Hematological Disorders Market, Mexico 41

5.1 Hematological Disorders Market, Mexico, Revenue ($m), 2018-2033 41

5.1.1 Hematology Tests Market, Mexico, Revenue ($m), by Segment, 2018-2033 43

5.1.2 Hemostasis Tests Market, Mexico, Revenue ($m), by Segment, 2018-2033 46

5.2 Hematological Disorders Market, Mexico, Volume (Units), 2018-2033 49

5.2.1 Hematology Tests Market, Mexico, Volume (Units), by Segment, 2018-2033 51

5.2.2 Hemostasis Tests Market, Mexico, Volume (Units), by Segment, 2018-2033 55

5.3 Hematological Disorders Market, Mexico, Average Price ($) , 2018-2033 58

5.4 Hematological Disorders Market, Mexico, Company Share by Revenue ($m), 2024 60

6 Hematological Disorders Market, United States 62

6.1 Hematological Disorders Market, United States, Revenue ($m), 2018-2033 62

6.1.1 Hematology Tests Market, United States, Revenue ($m), by Segment, 2018-2033 64

6.1.2 Hemostasis Tests Market, United States, Revenue ($m), by Segment, 2018-2033 66

6.2 Hematological Disorders Market, United States, Volume (Units), 2018-2033 69

6.2.1 Hematology Tests Market, United States, Volume (Units), by Segment, 2018-2033 71

6.2.2 Hemostasis Tests Market, United States, Volume (Units), by Segment, 2018-2033 75

6.3 Hematological Disorders Market, United States, Average Price ($) , 2018-2033 78

6.4 Hematological Disorders Market, United States, Company Share by Revenue ($m), 2024 80

7 Overview of Key Companies in North America Hematological Disorders Market 82

7.1 Abbott Laboratories 82

7.1.1 Company Overview 82

7.2 F. Hoffmann-La Roche Ltd 82

7.2.1 Company Overview 82

7.3 Sysmex Corp 82

7.3.1 Company Overview 82

7.4 Siemens AG 82

7.4.1 Company Overview 82

7.5 WerfenLife SA 83

7.5.1 Company Overview 83

7.6 Danaher Corp 83

7.6.1 Company Overview 83

7.7 Diagnostica Stago SAS 83

7.7.1 Company Overview 83

7.8 Quidel Corp 83

7.8.1 Company Overview 83

7.9 Thermo Fisher Scientific Inc 84

7.9.1 Company Overview 84

7.10 Siemens Healthineers AG 84

7.10.1 Company Overview 84

8 Hematological Disorders Market Pipeline Products 85

9 Recent Developments 87

9.1 Corporate Communications 87

9.1.1 Oct 16, 2024: PatientPoint CEO Sean Slovenski Shares Vision for Future of Health Care, Creates New Innovation Network Fueled by Partnerships and Appoints Chief Experience and Innovation Officer 87

9.1.2 Oct 02, 2024: Quanterix Adds Ivana Magovcevic-Liebisch to Board of Directors 87

9.1.3 Aug 20, 2024: Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer 88

9.1.4 Aug 19, 2024: Jeffrey Elliott Appointed to Quanterix’s Board of Directors 88

9.2 Government and Public Interest 89

9.2.1 Jan 02, 2025: Quanterix to Present at the 43rd Annual J.P. Morgan Healthcare Conference 89

9.2.2 Aug 29, 2024: Quanterix to Participate at the Morgan Stanley 22nd Annual Global Healthcare Conference 89

9.3 Other Significant Developments 89

9.3.1 Jan 13, 2025: Rigel Provides Business Update and 2025 Outlook 89

9.3.2 Jan 10, 2025: Quanterix To Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- And Tissue-Based Protein Biomarkers 91

9.4 Product News 92

9.4.1 Mar 18, 2025: Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) 2025 Annual Meeting 92

9.4.2 Feb 04, 2025: Blood Test Eases Diagnosis of Invasive Mold Disease 93

9.4.3 Feb 03, 2025: At SCOPE 2025, ConcertAI Announces Major Advances in Trial Technologies for Research Sites and Sponsors 94

9.4.4 Sep 17, 2024: The Results Of a Test Created In Barcelona For The Detection Of Multiple Cancers Are Presented at ESMO 94

10 Appendix 95

10.1 Research Methodology 96

10.1.1 Coverage 96

10.1.2 Secondary Research 96

10.1.3 Primary Research 96

10.1.4 Market Modeling and Forecasting 97

10.1.5 Company Share Analysis 98

10.1.6 Benchmarking 99

10.2 GlobalData Consulting 100

10.3 Contact Us 100

10.4 Disclaimer 100

Table

Table 1: Hematological Disorders Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033 12

Table 2: Hematological Disorders Market, North America, Revenue ($m), USD Constant, 2018-2033 15

Table 3: Hematological Disorders Market, North America, Volume (Units), 2018-2033 17

Table 4: Hematological Disorders Market, North America, Volume (Units), 2018-2033 19

Table 5: Hematological Disorders Market, North America, Company Share by Revenue ($m), 2024 21

Table 6: Hematological Disorders Market, Canada, Revenue ($m), USD Constant, 2018-2033 23

Table 7: Hematology Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033 25

Table 8: Hemostasis Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033 27

Table 9: Hematological Disorders Market, Canada, Volume (Units), 2018-2033 29

Table 10: Hematology Tests Market, Canada, Volume (Units), 2018-2033 31

Table 11: Hemostasis Tests Market, Canada, Volume (Units), 2018-2033 35

Table 12: Hematological Disorders Market, Canada, Average Price ($), 2018-2033 37

Table 13: Hematological Disorders Market, Canada, Company Share by Revenue ($m), 2024 40

Table 14: Hematological Disorders Market, Mexico, Revenue ($m), USD Constant, 2018-2033 42

Table 15: Hematology Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033 44

Table 16: Hemostasis Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033 47

Table 17: Hematological Disorders Market, Mexico, Volume (Units), 2018-2033 50

Table 18: Hematology Tests Market, Mexico, Volume (Units), 2018-2033 52

Table 19: Hemostasis Tests Market, Mexico, Volume (Units), 2018-2033 56

Table 20: Hematological Disorders Market, Mexico, Average Price ($), 2018-2033 58

Table 21: Hematological Disorders Market, Mexico, Company Share by Revenue ($m), 2024 61

Table 22: Hematological Disorders Market, United States, Revenue ($m), USD Constant, 2018-2033 63

Table 23: Hematology Tests Market, United States, Revenue ($m), USD Constant, 2018-2033 65

Table 24: Hemostasis Tests Market, United States, Revenue ($m), USD Constant, 2018-2033 67

Table 25: Hematological Disorders Market, United States, Volume (Units), 2018-2033 70

Table 26: Hematology Tests Market, United States, Volume (Units), 2018-2033 72

Table 27: Hemostasis Tests Market, United States, Volume (Units), 2018-2033 76

Table 28: Hematological Disorders Market, United States, Average Price ($), 2018-2033 78

Table 29: Hematological Disorders Market, United States, Company Share by Revenue ($m), 2024 81

Table 30: Hematological Disorders Market Pipeline Products 85

Table 31: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 97

Figures

Figure 1: Hematological Disorders Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033 11

Figure 2: Hematological Disorders Market, North America, Revenue ($m), USD Constant, 2018-2033 13

Figure 3: Hematological Disorders Market, North America, Volume (Units), 2018-2033 16

Figure 4: Hematological Disorders Market, North America, Volume (Units), 2018-2033 18

Figure 5: Hematological Disorders Market, North America, Company Share (%), 2024 20

Figure 6: Hematological Disorders Market, Canada, Revenue ($m), USD Constant, 2018-2033 22

Figure 7: Hematology Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033 24

Figure 8: Hemostasis Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033 26

Figure 9: Hematological Disorders Market, Canada, Volume (Units), 2018-2033 28

Figure 10: Hematology Tests Market, Canada, Volume (Units), 2018-2033 30

Figure 11: Hemostasis Tests Market, Canada, Volume (Units), 2018-2033 34

Figure 12: Hematological Disorders Market, Canada, Company Share (%), 2024 39

Figure 13: Hematological Disorders Market, Mexico, Revenue ($m), USD Constant, 2018-2033 41

Figure 14: Hematology Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033 43

Figure 15: Hemostasis Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033 46

Figure 16: Hematological Disorders Market, Mexico, Volume (Units), 2018-2033 49

Figure 17: Hematology Tests Market, Mexico, Volume (Units), 2018-2033 51

Figure 18: Hemostasis Tests Market, Mexico, Volume (Units), 2018-2033 55

Figure 19: Hematological Disorders Market, Mexico, Company Share (%), 2024 60

Figure 20: Hematological Disorders Market, United States, Revenue ($m), USD Constant, 2018-2033 62

Figure 21: Hematology Tests Market, United States, Revenue ($m), USD Constant, 2018-2033 64

Figure 22: Hemostasis Tests Market, United States, Revenue ($m), USD Constant, 2018-2033 66

Figure 23: Hematological Disorders Market, United States, Volume (Units), 2018-2033 69

Figure 24: Hematology Tests Market, United States, Volume (Units), 2018-2033 71

Figure 25: Hemostasis Tests Market, United States, Volume (Units), 2018-2033 75

Figure 26: Hematological Disorders Market, United States, Company Share (%), 2024 80

North America Hematological Disorders Market Outlook to 2033: Hematology Tests and Hemostasis Tests standard reports

Currency USD

Single User

$5,995

Can be used by individual purchaser only

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS

Related reports

View more In Vitro Diagnostics reports

Medical Devices

New

United States Neuromodulation Devices Market Outlook to 2033 - Implantable…

Medical Devices

New

United Kingdom Neuromodulation Devices Market Outlook to 2033 - Implantable…

Medical Devices

New

Brazil Neuromodulation Devices Market Outlook to 2033 - Implantable Neuromodulation…

Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at North America Hematological Disorders Market Outlook to 2033: Hematology Tests and Hemostasis Tests in real time.

Access a live North America Hematological Disorders Market Outlook to 2033: Hematology Tests and Hemostasis Tests dashboard for 12 months, with up-to-the-minute insights.
Fuel your decision making with real-time deal coverage and media activity.
Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.

Tell me more

Reports

Reports by Sector

Report Type

North America Hematological Disorders Market Outlook to 2033: Hematology Tests and Hemostasis Tests

Scope

Reasons to Buy

Table of Contents

Table

Figures

Undecided about purchasing this report?

Get in touch to find out about multi-purchase discounts

Related reports